Search

Search Constraints

You searched for: Author/Creator Haydu, Lauren

Search Results

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

3. Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018)

4. Determination of prognosis in metastatic melanoma through integration of clinico‐pathologic, mutation, mRNA, microRNA, and protein information. Issue 4 (24th July 2014)

5. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (November 2018)

6. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. Issue 1 (December 2016)

7. OTHR-08. PREDICTION OF RISK OF CENTRAL NERVOUS SYSTEM METASTASIS FOR AJCC 8TH EDITION STAGE III MELANOMA PATIENTS. (12th August 2019)

8. Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018)

9. RADT-13. EARLY CONCURRENT IMMUNOTHERAPY WITH STEREOTACTIC RADIOSURGERY IS ASSOCIATED WITH PROLONGED SURVIVAL AND DECREASED DISTANT BRAIN FAILURE IN PATIENTS WITH NEWLY DIAGNOSED MELANOMA BRAIN METASTASES (MBM). (9th November 2020)